Aspire Biopharma Holdings Inc (ASBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,167 | 5,857 | 1,004 | 1,948 | 206 |
| Inventories | 289 | 370 | 253 | 35 | N/A |
| TOTAL | $13,466 | $7,117 | $1,312 | $2,403 | $989 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 75 | 0 | 0 | 0 | 0 |
| TOTAL | $75 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $13,541 | $7,117 | $1,312 | $2,403 | $989 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 2,791 | 6,240 | 5,643 |
| Accounts payable and accrued liabilities | 972 | 1,653 | 1,368 | 1,415 | 2,084 |
| Accrued Expenses | 714 | N/A | 1,009 | 267 | N/A |
| Other current liabilities | 0 | N/A | 41 | 3,554 | N/A |
| TOTAL | $1,686 | $3,152 | $7,593 | $13,861 | $10,557 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 97 | 96 | 96 | 10 | 49 |
| TOTAL | $97 | $96 | $96 | $10 | $49 |
| Total Liabilities | $1,783 | $3,249 | $7,689 | $13,870 | $10,606 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,403 | 1,295 | 167 | 89 | 41 |
| Common Shares | 0 | 0 | 0 | 5 | 5 |
| Retained earnings | -31,749 | -30,481 | -27,258 | -22,550 | -20,700 |
| TOTAL | $11,758 | $3,869 | $-6,376 | $-11,467 | $-9,617 |
| Total Liabilities And Equity | $13,541 | $7,117 | $1,312 | $2,403 | $989 |